Top

Published in:

01-08-2011 | Original Article

Lack of evidence for association of two functional SNPs of CHI3L1 gene (HC-gp39) with rheumatoid arthritis

Authors: Sanjeev K. Srivastava, Péter Antal, János Gál, Gábor Hullám, Ágnes F. Semsei, György Nagy, András Falus, Edit I. Buzás

Published in: Rheumatology International | Issue 8/2011

Abstract

CHI3L1 gene encodes for a glycoprotein (HC-gp39 or YKL40) secreted by synovial fibroblasts, macrophages, neutrophil granulocytes and chondrocytes. Its expression is under the control of NF-kB. It is regarded as an acute phase protein, and its levels are significantly elevated in rheumatic diseases. Furthermore, HC-gp39 has been shown to be recognized by autoreactive T cells in rheumatoid arthritis. In the present study, we have examined two functional variants of the promoter region of CHI3L1 gene (CHI3L1-1 (rs4950928) and CHI3L1-2 (rs10399931) that have been reported earlier to be associated with schizophrenia and sarcoidosis. We used TaqMan allelic discrimination assays to study the genotypes of Hungarian patients with rheumatoid arthritis (n = 182) and of healthy controls (n = 194). No significant association of the investigated SNPs with the disease was found. Here we report that CHI3L1 SNPs, shown to be involved in the predisposition of schizophrenia, are not associated with rheumatoid arthritis.

Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903–911. doi:10.1016/S0140-6736(01)06075-5

Lorentzen JC, Flornes L, Eklow C, Backdahl L, Ribbhammar U, Guo JP (2007) Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum 56:2620–2632. doi:10.1002/art.22813 PubMedCrossRef

Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5:151–157. doi:10.1038/sj.gene.6364045 PubMedCrossRef

Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330–337. doi:10.1086/422827 PubMedCrossRef

Orozco G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, Torres B, Caliz RA (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52:219–224. doi:10.1002/art.20771

Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology 46:49–56. doi:10.1093/rheumatology/kel170 PubMedCrossRef

Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977–986. doi:10.1056/NEJMoa073003 PubMedCrossRef

Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK (2007) Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 13:455–460. doi:10.2119/2007-00072 PubMed

Orozco G, Alizadeh BZ, Delgado-Vega AM, Gonzalez-Gay MA, Balsa A, Pascual-Salcedo D (2008) Association of STAT4 gene with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum 58:1974–1980. doi:10.1002/art.23549 PubMedCrossRef

10.

Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J (2007) Rheumatoid arthritis association at 6q23. Nat Genet 39:1431–1433. doi:10.1038/ng.2007.32 PubMedCrossRef

11.

Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39:1477–1482. doi:10.1038/ng.2007.27 PubMedCrossRef

12.

Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B (2007) TRAF1–C5 as a risk locus for rheumatoid arthritis—a genomewide study. N Engl J Med 357:1199–1209. doi:10.1056/NEJMoa073491 PubMedCrossRef

13.

Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G (2007) A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 4:e278. doi:10.1371/journal.pmed.0040278 PubMedCrossRef

14.

Kroot E, Van Leeuwen MA, Van Rijswijk MH, Prevoo M, Van‘t Hof M, Van de Putte LBA, Van Riel PLC (2000) No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 59:954–958. doi:10.1136/ard.59.12.954 PubMedCrossRef

15.

Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Iwata Y, Tsuchiya KJ, Sugihara G, Kikuchi M, Okazaki Y, Yoshikawa T (2009) Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations. Am J Med Genet B Neuropsychiatr Genet 150B(4):508–514. doi:10.1002/ajmg.b.30847

16.

Nyirkos P, Golds EE (1990) Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 269:265–268PubMed

17.

Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial fluid cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810PubMed

18.

Recklies AD, Ling H, White C, Bernier SM (2005) Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 280:41213–41221. doi:10.1074/jbc.M510146200 PubMedCrossRef

19.

Connor J, Dodds R, Emery J, Kirkpatrick R, Rosenberg M, Gowen M. (2000) Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthr Cartil 8:87–95. doi:10.1053/joca.1999.0276

20.

Verheijden GF, Rijnders AW, Bos E, Coenen-de Roo CJJ, van Staveren CJ, Miltenburg AM (1997) Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 40:1115–1125. doi:10.1002/1529-0131(199706)

21.

Vos K, Steenbakkers P, Miltenburg A, Bos E, Van den Heuve M, Van Hogezand R, De Vries R, Breedveld F, Boots A (2000) Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis 59:544–548. doi:10.1136/ard.59.7.544 PubMedCrossRef

22.

Johansen JS, Jensen HS, Price PA (1993) A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 32:949–955PubMedCrossRef

23.

Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA (1996) Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 35:553–559PubMedCrossRef

24.

Zhao X, Tang R, Gao B, Shi Y, Zhou J, Guo S, Zhang J, Wang Y, Tang W, Meng J, Li S, Wang H, Ma G, Lin C, Xiao Y, Feng G, Lin Z, Zhu S, Xing Y, Sang H, St Clair D, He L (2007) Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 80:12–18. doi:10.1086/510438

25.

Kruit A, Grutters J, Ruven H, Moorsel C, Van Den Bosch J (2007) A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respiratory Medicine 101:1563–1571. doi:10.1016/j.rmed.2006.12.006

26.

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef

27.

Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact tests of Hardy–Weinberg equilibrium. Am J Hum Genet 76:887–893. doi:10.1086/429864

28.

Ling H, Recklies AD (2004) The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J 380:651–659. doi:10.1042/BJ20040099

29.

Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF Jr, Nicolae DL, Elias JA, Chupp GL (2008) Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358:1682–1691. doi:10.1056/NEJMoa0708801

Title: Lack of evidence for association of two functional SNPs of CHI3L1 gene (HC-gp39) with rheumatoid arthritis
Authors: Sanjeev K. Srivastava
Péter Antal
János Gál
Gábor Hullám
Ágnes F. Semsei
György Nagy
András Falus
Edit I. Buzás
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 8/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1396-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Lack of evidence for association of two functional SNPs of CHI3L1 gene (HC-gp39) with rheumatoid arthritis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2011

Meta-analysis of TNF-α promoter –308A/G polymorphism and SLE susceptibility in Asian populations

Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis

Eruptive molluscum contagiosums in a patient with rheumatoid arthritis and lung cancer

Experimental animal models of osteonecrosis

Lack of association of FcγRIIIb polymorphisms with systemic lupus erythematosus: a meta-analysis

Anti-Sm faces a threat to its reigning position as the marker antibody

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page